Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma.

PubWeight™: 0.88‹?›

🔗 View Article (PMC 3735494)

Published in PLoS One on August 06, 2013

Authors

Tonghai Xing1, Li Huang, Zhenhai Yu, Lin Zhong, Shuyun Wang, Zhihai Peng

Author Affiliations

1: Department of General Surgery, Shanghai First People's Hospital, Shanghai Jiao Tong University, Organ Transplantation Center of Shanghai, Shanghai, China.

Articles cited by this

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16

Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol (2010) 5.87

Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation (2008) 2.48

Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett (2008) 1.80

Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial. Liver Transpl (2002) 1.58

Current status of liver diseases in Korea: hepatocellular carcinoma. Korean J Hepatol (2009) 1.42

Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge. Transpl Int (2012) 1.22

Hepatocellular carcinoma: focus on different aspects of management. ISRN Oncol (2012) 1.21

Meta-analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma. Aliment Pharmacol Ther (2012) 1.17

Seroprevalence of hepatitis B surface antigen among pregnant women in Jiangsu, China, 17 years after introduction of hepatitis B vaccine. Int J Gynaecol Obstet (2010) 1.15

Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China. J Cancer Res Clin Oncol (2009) 1.12

Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage. Liver Transpl (2004) 1.06

Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. Transplantation (2010) 1.06

Control of hepatitis B in China: prevention and treatment. Expert Rev Anti Infect Ther (2011) 1.05

Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. Transplantation (1995) 1.03

Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria. Transplant Proc (2008) 1.03

Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study. Liver Transpl (2005) 0.99

A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl (2011) 0.97

Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation. Transplantation (2008) 0.96

Corticosteroid-free immunosuppression in liver transplantation: a meta-analysis and meta-regression of outcomes. Transpl Int (2009) 0.95

Steroid withdrawal at day 14 after liver transplantation: a double-blind, placebo-controlled study. Liver Transpl (2004) 0.93

Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C. J Gastroenterol Hepatol (2011) 0.93

The role of basiliximab induction therapy in organ transplantation. Expert Opin Biol Ther (2007) 0.91

Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapy. Cancer Lett (2005) 0.90

Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience. World J Gastroenterol (2006) 0.86

The relationship between recurrences and immunosuppression on living donor liver transplantation for hepatocellular carcinoma. Transplant Proc (2012) 0.86

Basiliximab in a triple-drug regimen with tacrolimus and steroids in liver transplantation. Transplant Proc (2005) 0.85

Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial. Transplantation (2008) 0.84

Safety and efficacy of steroid-free immunosuppression with tacrolimus and daclizumab in liver transplant recipients: 6-year follow-up in a single center. Transplant Proc (2009) 0.82

Early steroid withdrawal after liver transplantation for hepatocellular carcinoma. World J Gastroenterol (2007) 0.82

Survival in liver transplant recipients with hepatitis B- or hepatitis C-associated hepatocellular carcinoma: the Chinese experience from 1999 to 2010. PLoS One (2013) 0.81

Insulin and dexamethasone inhibit TGF-beta-induced apoptosis of hepatoma cells upstream of the caspase activation cascade. Toxicology (2004) 0.80

Initial immunosuppression with or without basiliximab: a comparative study. Transplant Proc (2012) 0.79

Glucocorticoid protects hepatoma cells against metabolic stress-induced cell death. Int J Oncol (2008) 0.79

Articles by these authors

The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat Med (2004) 3.34

Dendritic cell apoptosis in the maintenance of immune tolerance. Science (2006) 3.33

Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene (2003) 2.79

A complete sequence of the T. tengcongensis genome. Genome Res (2002) 2.60

Six1 is required for the early organogenesis of mammalian kidney. Development (2003) 2.47

Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res (2003) 2.38

Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature (2005) 2.37

The role of Six1 in mammalian auditory system development. Development (2003) 2.22

Development of a virus-induced gene-silencing system for hexaploid wheat and its use in functional analysis of the Lr21-mediated leaf rust resistance pathway. Plant Physiol (2005) 2.02

The Use of Opioid Analgesics following Common Upper Extremity Surgical Procedures: A National, Population-Based Study. Plast Reconstr Surg (2016) 1.94

Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism. Gut (2011) 1.91

Refractive error and visual impairment in school children in rural southern China. Ophthalmology (2006) 1.84

Inhibition of HIV-1 maturation via drug association with the viral Gag protein in immature HIV-1 particles. J Biol Chem (2005) 1.66

Intussusception in infants younger than 3 months: a single center's experience. World J Pediatr (2010) 1.57

MicroRNA-143 as a tumor suppressor for bladder cancer. J Urol (2009) 1.56

The gene Sr33, an ortholog of barley Mla genes, encodes resistance to wheat stem rust race Ug99. Science (2013) 1.55

Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas. Am J Surg Pathol (2006) 1.50

Activation of estrogen receptor-alpha by the anion nitrite. Cancer Res (2008) 1.47

Expression and role of neuroglobin in rats with sepsis-associated encephalopathy. Crit Care Med (2014) 1.46

A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis. Cancer Res (2011) 1.45

Genome analyses of Icelandic strains of Sulfolobus islandicus, model organisms for genetic and virus-host interaction studies. J Bacteriol (2011) 1.45

Arabidopsis acyl-CoA-binding protein ACBP3 participates in plant response to hypoxia by modulating very-long-chain fatty acid metabolism. Plant J (2014) 1.44

In situ imaging of the conducting filament in a silicon oxide resistive switch. Sci Rep (2012) 1.43

Prognostic role of serum carbohydrate antigen 19-9 levels in patients with resectable hepatocellular carcinoma. Tumour Biol (2015) 1.42

Reconstruction of the Irradiated Breast: A National Claims-Based Assessment of Postoperative Morbidity. Plast Reconstr Surg (2017) 1.40

Combination of channel-TURP and ILC versus standard TURP or ILC for elderly with benign prostatic hyperplasia: a randomized prospective trial. Urol Int (2011) 1.39

The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model. Blood (2010) 1.35

The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion. J Biol Chem (2003) 1.35

Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump. J Biol Chem (2003) 1.33

Construction of a SNP-based genetic linkage map in cultivated peanut based on large scale marker development using next-generation double-digest restriction-site-associated DNA sequencing (ddRADseq). BMC Genomics (2014) 1.30

IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. Ann Surg Oncol (2009) 1.29

Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation. Mol Oncol (2012) 1.28

Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity. Blood (2007) 1.27

Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents. J Med Chem (2009) 1.26

Sulfolobus tengchongensis spindle-shaped virus STSV1: virus-host interactions and genomic features. J Virol (2005) 1.26

Anti-AIDS agents 69. Moronic acid and other triterpene derivatives as novel potent anti-HIV agents. J Med Chem (2006) 1.25

Cardiac small conductance Ca2+-activated K+ channel subunits form heteromultimers via the coiled-coil domains in the C termini of the channels. Circ Res (2010) 1.24

Cre reporter mouse expressing a nuclear localized fusion of GFP and beta-galactosidase reveals new derivatives of Pax3-expressing precursors. Genesis (2008) 1.23

Regulation of the lifespan in dendritic cell subsets. Mol Immunol (2007) 1.23

Red cell distribution width as a novel predictor of mortality in ICU patients. Ann Med (2010) 1.23

Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma. J Exp Clin Cancer Res (2013) 1.21

Ssh10b, a conserved thermophilic archaeal protein, binds RNA in vivo. Mol Microbiol (2003) 1.20

Melanocyte-like cells in the heart and pulmonary veins contribute to atrial arrhythmia triggers. J Clin Invest (2009) 1.19

Design, synthesis, and preclinical evaluations of novel 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) drug candidates. J Med Chem (2012) 1.18

Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma. J Biol Chem (2009) 1.18

Metagenomic insights into the fibrolytic microbiome in yak rumen. PLoS One (2012) 1.17

New betulinic acid derivatives for bevirimat-resistant human immunodeficiency virus type-1. J Med Chem (2013) 1.16

H3.3 actively marks enhancers and primes gene transcription via opening higher-ordered chromatin. Genes Dev (2013) 1.14

Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity. J Biol Chem (2002) 1.14

Caspase-9-induced mitochondrial disruption through cleavage of anti-apoptotic BCL-2 family members. J Biol Chem (2007) 1.13

Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China. J Cancer Res Clin Oncol (2009) 1.12

Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors. J Med Chem (2009) 1.12

Revealing the essentiality of multiple archaeal pcna genes using a mutant propagation assay based on an improved knockout method. Microbiology (2010) 1.11

KLF4-mediated negative regulation of IFITM3 expression plays a critical role in colon cancer pathogenesis. Clin Cancer Res (2011) 1.11

Anti-AIDS agents 79. Design, synthesis, molecular modeling and structure-activity relationships of novel dicamphanoyl-2',2'-dimethyldihydropyranochromone (DCP) analogs as potent anti-HIV agents. Bioorg Med Chem (2010) 1.08

Gene-expression profiling in Chinese patients with colon cancer by coupling experimental and bioinformatic genomewide gene-expression analyses: identification and validation of IFITM3 as a biomarker of early colon carcinogenesis. Cancer (2008) 1.08

Resistive switches and memories from silicon oxide. Nano Lett (2010) 1.08

Tanshinone IIA: A Promising Natural Cardioprotective Agent. Evid Based Complement Alternat Med (2012) 1.07

Where self-control comes from: on the development of self-control and its relationship to deviance over time. Dev Psychol (2010) 1.07

Phospholipase C epsilon plays a suppressive role in incidence of colorectal cancer. Med Oncol (2011) 1.07

Ash2l interacts with Tbx1 and is required during early embryogenesis. Exp Biol Med (Maywood) (2010) 1.06

Reg4 protects against acinar cell necrosis in experimental pancreatitis. Gut (2010) 1.06

Diarylaniline derivatives as a distinct class of HIV-1 non-nucleoside reverse transcriptase inhibitors. J Med Chem (2010) 1.06

YAP/TEAD-mediated transcription controls cellular senescence. Cancer Res (2013) 1.06

Serum starvation induced cell cycle synchronization facilitates human somatic cells reprogramming. PLoS One (2012) 1.06

Genetic analysis of chikungunya viruses imported to mainland China in 2008. Virol J (2010) 1.05

Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of human immunodeficiency virus type 1. Antimicrob Agents Chemother (2007) 1.05

Silicon oxide: a non-innocent surface for molecular electronics and nanoelectronics studies. J Am Chem Soc (2010) 1.05

The critical role of dysregulated FOXM1-PLAUR signaling in human colon cancer progression and metastasis. Clin Cancer Res (2012) 1.05

Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer. Ann Surg Oncol (2011) 1.05

Nicotinamidase modulation of NAD+ biosynthesis and nicotinamide levels separately affect reproductive development and cell survival in C. elegans. Development (2009) 1.04

Anti-AIDS agents 81. Design, synthesis, and structure-activity relationship study of betulinic acid and moronic acid derivatives as potent HIV maturation inhibitors. J Med Chem (2010) 1.04

Multivariate statistical analysis of heavy metals in street dust of Baoji, NW China. J Hazard Mater (2009) 1.04

Analysis of 106 kb of contiguous DNA sequence from the D genome of wheat reveals high gene density and a complex arrangement of genes related to disease resistance. Genome (2002) 1.03

Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus. Am J Pathol (2005) 1.03

Biochemical and structural characterization of Cren7, a novel chromatin protein conserved among Crenarchaea. Nucleic Acids Res (2007) 1.03

Chinese medicine tongxinluo significantly lowers serum lipid levels and stabilizes vulnerable plaques in a rabbit model. J Ethnopharmacol (2009) 1.03

Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype. Proc Natl Acad Sci U S A (2010) 1.02

Human CD59 inhibitor sensitizes rituximab-resistant lymphoma cells to complement-mediated cytolysis. Cancer Res (2011) 1.02

Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43. Cancer Res (2009) 1.02

Biochemical characterization of an ATP-dependent DNA ligase from the hyperthermophilic crenarchaeon Sulfolobus shibatae. Extremophiles (2002) 1.02

Degradation of alpha-actin filaments in venous smooth muscle cells in response to mechanical stretch. Am J Physiol Heart Circ Physiol (2003) 1.01

Resistive switching in nanogap systems on SiO2 substrates. Small (2009) 1.01

Decreased expression of miR-126 correlates with metastatic recurrence of hepatocellular carcinoma. Clin Exp Metastasis (2013) 1.00

Episodic HIV Risk Behavior Can Greatly Amplify HIV Prevalence and the Fraction of Transmissions from Acute HIV Infection. Stat Commun Infect Dis (2012) 1.00

Anti-AIDS agents 90. novel C-28 modified bevirimat analogues as potent HIV maturation inhibitors. J Med Chem (2012) 1.00

A natural small molecule harmine inhibits angiogenesis and suppresses tumour growth through activation of p53 in endothelial cells. PLoS One (2012) 1.00

Screening of new tumor suppressor genes in sporadic colorectal cancer patients. Hepatogastroenterology (2009) 0.99

Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels. Br J Pharmacol (2009) 0.99

HDL of patients with type 2 diabetes mellitus elevates the capability of promoting breast cancer metastasis. Clin Cancer Res (2012) 0.99

Sulfolobus tengchongensis sp. nov., a novel thermoacidophilic archaeon isolated from a hot spring in Tengchong, China. Extremophiles (2003) 0.99

Disruption of a GATA4/Ankrd1 signaling axis in cardiomyocytes leads to sarcomere disarray: implications for anthracycline cardiomyopathy. PLoS One (2012) 0.99

Relationship between thyroid function and ICU mortality: a prospective observation study. Crit Care (2012) 0.98

Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression. Cancer Res (2011) 0.98

Characterization of the human UBE3B gene: structure, expression, evolution, and alternative splicing. Genomics (2003) 0.98

Optimization of 2,4-diarylanilines as non-nucleoside HIV-1 reverse transcriptase inhibitors. Bioorg Med Chem Lett (2012) 0.98

Upregulation of barrel GABAergic neurons is associated with cross-modal plasticity in olfactory deficit. PLoS One (2010) 0.98

Porcine reproductive and respiratory syndrome virus induces autophagy to promote virus replication. Autophagy (2012) 0.98

Dynamics of chloroplast proteome in salt-stressed mangrove Kandelia candel (L.) Druce. J Proteome Res (2013) 0.98